Nonoperating Income (Expense) in USD of BioCardia, Inc. from 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
BioCardia, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from 2015 to Q3 2025.
  • BioCardia, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $5K, a 73.7% decline year-over-year.
  • BioCardia, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $46K, a 9.52% increase year-over-year.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2024 was $55K, a 24.7% decline from 2023.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2023 was $73K.
  • BioCardia, Inc. annual Nonoperating Income (Expense) for 2022 was -$6K, a 186% decline from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

BioCardia, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $46K $5K -$14K -73.7% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $60K $2K -$1K -33.3% 01 Apr 2025 30 Jun 2025 10-Q/A 29 Oct 2025
Q1 2025 $61K $14K +$6K +75% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $55K $25K +$13K +108% 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $42K $19K -$5K -20.8% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $47K $3K -$25K -89.3% 01 Apr 2024 30 Jun 2024 10-Q/A 29 Oct 2025
Q1 2024 $72K $8K -$1K -11.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $73K $12K +$22K 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $51K $24K +$21K +700% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $30K $28K +$29K 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $1K $9K +$7K +350% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$6K -$10K -$10K 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $4K $3K +$1K +50% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $3K -$1K -$3K -150% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $6K $2K -$1K -33.3% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $7K $0 -$509K -100% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $516K $2K +$2K 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $514K $2K +$1K +100% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $513K $3K -$12K -80% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022
Q4 2020 $525K $509K +$474K +1354% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $51K $0 +$565K 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$514K $1K -$11K -91.7% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$503K $15K -$7K -31.8% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$496K $35K +$17K +94.4% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 -$513K -$565K -$591K -2273% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $78K $12K -$23K -65.7% 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $101K $22K -$14K -38.9% 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020
Q4 2018 $115K $18K -$19K -51.4% 01 Oct 2018 31 Dec 2018 10-K 09 Apr 2020
Q3 2018 $134K $26K -$12K -31.6% 01 Jul 2018 30 Sep 2018 10-Q 19 Nov 2019
Q2 2018 $146K $35K +$12K +52.2% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 $134K $36K +$37K 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q4 2017 $97K $37K +$147K 01 Oct 2017 31 Dec 2017 10-K 09 Apr 2020
Q3 2017 -$50K $38K +$1.61M 01 Jul 2017 30 Sep 2017 10-Q 08 Nov 2018
Q2 2017 -$1.66M $23K +$623K 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$2.28M -$1K +$419K +99.8% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 -$2.7M -$110K 01 Oct 2016 31 Dec 2016 10-K 02 Apr 2019
Q3 2016 -$1.57M 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$600K 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$420K 01 Jan 2016 31 Mar 2016 10-Q 11 May 2017

BioCardia, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $55K -$18K -24.7% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $73K +$79K 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 -$6K -$13K -186% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024
2021 $7K -$518K -98.7% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 $525K +$1.02M 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$496K -$611K -531% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 $115K +$18K +18.6% 01 Jan 2018 31 Dec 2018 10-K 09 Apr 2020
2017 $97K +$2.8M 01 Jan 2017 31 Dec 2017 10-K 09 Apr 2020
2016 -$2.7M -$1.41M -110% 01 Jan 2016 31 Dec 2016 10-K 02 Apr 2019
2015 -$1.29M 01 Jan 2015 31 Dec 2015 10-K 16 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.